MARKET

IMNN

IMNN

Imunon Inc
NASDAQ
1.070
-0.020
-1.83%
Closed 04:00 09/22 EDT
OPEN
1.100
PREV CLOSE
1.090
HIGH
1.102
LOW
1.040
VOLUME
256
TURNOVER
--
52 WEEK HIGH
1.990
52 WEEK LOW
1.040
MARKET CAP
10.02M
P/E (TTM)
-0.2916
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at IMNN last week (0911-0915)?
Weekly Report · 3d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Imunon (IMNN) and Laboratory (LH)
TipRanks · 6d ago
Weekly Report: what happened at IMNN last week (0904-0908)?
Weekly Report · 09/11 11:06
Weekly Report: what happened at IMNN last week (0828-0901)?
Weekly Report · 09/05 01:38
Weekly Report: what happened at IMNN last week (0821-0825)?
Weekly Report · 08/28 11:12
IMUNON Enters Into CRADA For Preclinical Studies Of PlaCCine Modality In Preventive Vaccines Against Lassa Virus
Benzinga · 08/24 20:13
H.C. Wainwright Reaffirms Their Buy Rating on Imunon (IMNN)
TipRanks · 08/11 10:25
Imunon Inc: Quarterly report
Press release · 08/10 14:10
More
About IMNN
Imunon, Inc. is a clinical-stage biotechnology company. It is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. It has two platform technologies: TheraPlas platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies, and the PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. Its lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer. IMNN-001 works by instructing the body to produce cancer fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, it is conducting preclinical studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus to validate its PLACCINE platform. Its platform technologies are based on the delivery of nucleic acids with synthetic delivery systems that are independent of viral vectors or devices.

Webull offers kinds of Imunon Inc stock information, including NASDAQ:IMNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMNN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IMNN stock methods without spending real money on the virtual paper trading platform.